Skip to main content

Advertisement

Log in

Mycobacterium abscessus exit-site infection in peritoneal dialysis patients: should we ever aim to salvage the catheter?

  • Case Report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

Improvements in the exit-site care for peritoneal dialysis (PD) patients have uncovered a trend for increasing incidence of rapidly growing nontuberculous mycobacterium exit-site infections (ESI). Among these, Mycobacterium abscessus is unique in terms of its high morbidity and treatment failure rates. The international society of PD guidelines encourage PD catheter removal in patients with M. abscessus peritonitis but, do not have evidence-based recommendations for the management of ESIs related to this organism. We report an unusual case in which an asymptomatic end-stage renal disease patient with multiple favorable clinical characteristics, i.e., no apparent immunodeficiency, sensitivity pattern showing possibility of treatment with multiple antibiotics, no evidence of peritonitis, and early clinical response, was treated with a 9-month combination antimicrobial regimen administered orally and intraperitoneally. Despite excellent clinical response with a resolution of the ESI, our patient relapsed quickly, within 30 days of stopping antimicrobial therapy and required PD catheter removal. Our case, taken together with available published case reports, highlights the futility of the conservative approach towards the M. abscessus ESI and makes the cases for early PD catheter removal in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure.1 
Figure.2 

Similar content being viewed by others

References

  1. Shen JI, Mitani AA, Saxena AB, Goldstein BA, Winkelmayer WC. Determinants of peritoneal dialysis technique failure in incident US patients. Perit Dial Int. 2013;33(2):155–66. https://doi.org/10.3747/pdi.2011.00233.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Szeto CC, Li PKT, Johnson DW, Bernardini J, Dong J, Figueiredo AE, et al. ISPD catheter-related infection recommendations: 2017 update. Perit Dial Int. 2017;37(2):141–54. https://doi.org/10.3747/pdi.2016.00120.

    Article  PubMed  Google Scholar 

  3. Singh H, Saha T. Exit-site infection due to nontubercular Mycobacteria in an immunocompromised peritoneal dialysis patient. Dialysis & Transplantation. 2008;37(10):401–9. https://doi.org/10.1002/dat.20225.

    Article  Google Scholar 

  4. Mooren V, Bleeker MWP, van Ingen J, Hermans MHA, Wever PC. Disseminated Mycobacterium abscessus infection in a peritoneal dialysis patient. IDCases. 2017;9:6–7. https://doi.org/10.1016/j.idcr.2017.05.001.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Yoshimura R, Kawanishi M, Fujii S, Yamauchi A, Takase K, Yoshikane K, et al. Peritoneal dialysis-associated infection caused by Mycobacterium abscessus: a case report. BMC Nephrol. 2018;19(1):341. https://doi.org/10.1186/s12882-018-1148-2.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Renaud CJ, Subramanian S, Tambyah PA, Lee EJ. The clinical course of rapidly growing nontuberculous Mycobacterial peritoneal dialysis infections in Asians: a case series and literature review. Nephrology (Carlton). 2011;16(2):174–9. https://doi.org/10.1111/j.1440-1797.2010.01370.x.

    Article  Google Scholar 

  7. Lo MW, Mak SK, Wong YY, Lo KC, Chan SF, Tong GM, et al. Atypical Mycobacterial exit-site infection and peritonitis in peritoneal dialysis patients on prophylactic exit-site gentamicin cream. Perit Dial Int. 2013;33(3):267–72. https://doi.org/10.3747/pdi.2011.00184.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Bernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L, et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol. 2005;16(2):539–45. https://doi.org/10.1681/ASN.2004090773.

    Article  CAS  PubMed  Google Scholar 

  9. Petrini B. Mycobacterium abscessus: an emerging rapid-growing potential pathogen. APMIS. 2006;114(5):319–28. https://doi.org/10.1111/j.1600-0463.2006.apm_390.x.

    Article  CAS  PubMed  Google Scholar 

  10. Macheras E, Roux A-L, Bastian S, Leão SC, Palaci M, Sivadon-Tardy V, et al. Multilocus sequence analysis and rpoB sequencing of Mycobacterium abscessus (sensu lato) strains. J Clin Microbiol. 2011;49(2):491–9. https://doi.org/10.1128/JCM.01274-10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Tsai S-F. Catheter related infection due to Mycobacterium abscessus in a patient under peritoneal dialysis. Therapeutic Apheresis and Dialysis. 2013;17(3):349–50. https://doi.org/10.1111/1744-9987.12005.

    Article  PubMed  Google Scholar 

  12. Tse KC, Lui SL, Cheng VC, Yip TP, Lo WK. A cluster of rapidly growing Mycobacterial peritoneal dialysis catheter exit-site infections. Am J Kidney Dis. 2007;50(1):e1–5. https://doi.org/10.1053/j.ajkd.2007.04.017.

    Article  PubMed  Google Scholar 

  13. Jiang SH, Roberts DM, Clayton PA, Jardine M. Non-tuberculous Mycobacterial PD peritonitis in Australia. Int Urol Nephrol. 2013;45(5):1423–8. https://doi.org/10.1007/s11255-012-0328-4.

    Article  PubMed  Google Scholar 

  14. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous Mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416. https://doi.org/10.1164/rccm.200604-571ST.

    Article  CAS  PubMed  Google Scholar 

  15. Ono E, Uchino E, Mori KP, Yokoi H, Toda N, Koga K, et al. Peritonitis due to Mycobacterium abscessus in peritoneal dialysis patients: case presentation and mini-review. Ren Replace Ther. 2018;4(1):52. https://doi.org/10.1186/s41100-018-0192-5.

    Article  Google Scholar 

  16. Kameyama H, Mori Y, Kimura T, Sugishita C, Adachi T, Sonomura K, et al. A case report of Mycobacterium abscessus peritonitis in a peritoneal dialysis patient. Ther Apher Dial. 2007;11(6):449–51. https://doi.org/10.1111/j.1744-9987.2007.00526.x.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank Dr. Kevin Fennelly (Senior Research Clinician, Laboratory of Chronic Airway Infection, Pulmonary Branch, Division of Intramural Research. National Institutes of Health) for his input on M. abscessus infection management.

Funding

A. M. Shukla reports the ongoing grant support from the Department of Veterans Affairs. The grant support is unrelated to and has no conflicts with the work published here.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ashutosh M. Shukla.

Ethics declarations

Conflict of interest

The authors have declared no conflict of interest exists.

Ethical standards

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individuals participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chamarthi, G., Kamboj, M., Archibald, L.K. et al. Mycobacterium abscessus exit-site infection in peritoneal dialysis patients: should we ever aim to salvage the catheter?. CEN Case Rep 10, 12–16 (2021). https://doi.org/10.1007/s13730-020-00506-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-020-00506-5

Keywords

Navigation